A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

Capital Medical University

Status: Enrolling

Conditions: Immunotherapy; ADR

Study type: Observational

Funder types: Other

Identifiers

NCT05669638

hongyanli1

Details and patient eligibility

About

The goal of this observational study is to learn about in the development process of adverse reactions of anti-PD1 immunotherapy. The main question it aims to observe:

• The autoantibody profile of patients
• The adverse reactions of patients
• The changes of immune cells and cytokine in patients

Full description

The goal of this observational study is to learn about the development process of adverse reactions of anti-PD1 immunotherapy. The main question it aims to observe:

• The autoantibody profile of patients
• The adverse reactions of patients
• The changes of immune cells and cytokine in patients (e.g., T cell, B cell, IL-6, etc.)

Enrollment: 80 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥ 18 years old.
2. Receiving anti-PD1 immunotherapy

Exclusion criteria

1. Vital signs are unstable
2. Functional impairment of immune system caused by other diseases or other reasons, such as Systemic lupus erythematosus (SLE), AIDS, etc.